iDtheinvestordatabase
Home / Directory / Oak HC/FT
Active: new fund Jul 2025 Verified 4 Nov 2026

Oak HC/FT

Growth equity investor working with founders in healthcare and financial services, with portfolio companies including AI-enabled businesses in both fields.

Type
VC firm
Location
Stamford, Connecticut, United States
Stages
Seed, Series A, Series B, Growth
Backs
Medtech and digital health, Fintech, B2B software
Sectors
Fintech, Healthtech and life sciences, AI, Insurtech
Fund size / AUM
Fund size not disclosed on Form D
Latest fund or filing
24 Jul 2025
Portfolio mix
Medtech and digital health 41%; Fintech 28%; B2B software 14%; Biotech and pharma 10%; Hardware 3%; Consumer products 3% (n=29)

Fund filings (SEC Form D)

Latest fund on file
Oak HC/FT Partners VI-A
Filed
24 Jul 2025 (new notice)
Fund size
Not disclosed on the filing

See this fund's filings on SEC EDGAR

Contacts on file

For Oak HC/FT, the paid file holds: 5 named decision-makers with roles; firm contact email (domain checked); LinkedIn page.

Get US Complete, $197 Free sample

One-time payment. No subscription. No account.

Notable investments

Maven ClinicDevoted HealthFeedzaiRilletChai Discovery

Sources

Last checked 4 Nov 2026. Is something wrong? Tell us.

Appears in 74 lists

Growth-stage insurtech investors in the US (15)Healthtech investors in Connecticut (16)Seed investors in Connecticut (17)AI investors in Connecticut (17)SaaS investors in Connecticut (17)Series B insurtech investors (21)Series A insurtech investors in the US (23)Growth-stage insurtech investors (29)Series B medtech investors in the US (36)Series A insurtech investors (40)Seed insurtech investors in the US (41)Venture capital firms in Connecticut (49)Insurtech venture capital firms in the US (56)Series B medtech investors (57)Series B fintech investors in the US (59)Seed insurtech investors (61)Series B healthtech investors in the US (69)Growth-stage medtech investors in the US (69)Series A medtech investors in the US (76)Insurtech investors (88)Growth-stage fintech investors in the US (97)Growth-stage medtech investors (107)Series B SaaS investors in the US (108)Growth-stage healthtech investors in the US (121)Series A medtech investors (125)Series B AI investors in the US (126)Series B fintech investors (127)Series A fintech investors in the US (145)Series B healthtech investors (160)Growth-stage AI investors in the US (162)Growth-stage SaaS investors in the US (162)Series A healthtech investors in the US (164)Series B investors in the US (165)Series B SaaS investors (196)Series B AI investors (204)Seed medtech investors in the US (205)Growth-stage fintech investors (214)Series A SaaS investors in the US (256)Seed medtech investors (278)Series A AI investors in the US (280)Growth-stage investors in the US (288)Series A fintech investors (294)Growth-stage AI investors (295)Growth-stage healthtech investors (316)Series B investors (339)Growth-stage SaaS investors (344)Seed fintech investors in the US (349)Medtech venture capital firms in the US (350)Series A investors in the US (372)Series A healthtech investors (401)Seed healthtech investors in the US (437)Medtech investors (457)Series A SaaS investors (475)Series A AI investors (500)Fintech venture capital firms in the US (525)Seed fintech investors (584)Seed SaaS investors in the US (666)Growth-stage investors (705)Healthtech venture capital firms in the US (709)Seed AI investors in the US (724)Seed healthtech investors (800)Fintech investors (846)Series A investors (864)Seed SaaS investors (1,010)Seed investors in the US (1,043)SaaS venture capital firms in the US (1,049)Seed AI investors (1,082)AI venture capital firms in the US (1,112)Healthtech investors (1,207)SaaS investors (1,529)Active venture capital firms in the US (1,574)AI investors (1,576)Seed investors (1,892)Venture capital firms in the US (2,975)